Induced Pluripotent Stem Cell Market Segmented By Hepatocytes, Fibroblasts, Keratinocytes, Neurons Cells in Drug Development, Regenerative Medicine, Toxicity Testing
Industry: Healthcare
Published Date: May-2018
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 271
Report ID: PMRREP17968
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Induced Pluripotent Stem cells Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Parent Market Overview
4.2. Induced Pluripotent Stem Cell Timeline
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
5. Macroeconomic Assumptions
6. Global Economic Outlook
6.1. Gross Domestic Product by Region & Country, 2006 – 2021
6.2. Healthcare Indicators
7. Key Inclusions
7.1. Usage Trend in Industry
7.2. Active Researchers in Stem Cell Research
7.3. Induced Pluripotent Stem Cell Therapy for Cardiovascular Disease
7.4. In-Vivo Modelling for Neurological Disorder Using Induced Pluripotent Stem Cells
7.5. Pipeline Assessment
8. North America Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
8.3.1. U.S.
8.3.2. Canada
8.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
8.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
8.5.1. Hepatocytes
8.5.2. Fibroblasts
8.5.3. Keratinocytes
8.5.4. Neurons
8.5.5. Others
8.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
8.7.1. Drug Development
8.7.2. Toxicity testing
8.7.3. Regenerative Medicine
8.7.4. Others
8.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
8.9.1. Academic & Research Institutes
8.9.2. Biotechnology companies
8.9.3. Others
8.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
8.11. Drivers and Restraints: Impact Analysis
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Cell Type
8.12.3. By Application
8.12.4. By End User
8.13. Key Market Participants – Intensity Mapping
8.14. Drivers and Restraints – Impact Analysis
9. Latin America Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
9.3.1. Argentina
9.3.2. Brazil
9.3.3. Mexico
9.3.4. Rest of Latin America
9.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
9.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
9.5.1. Hepatocytes
9.5.2. Fibroblasts
9.5.3. Keratinocytes
9.5.4. Neurons
9.5.5. Others
9.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
9.7.1. Drug Development
9.7.2. Toxicity testing
9.7.3. Regenerative Medicine
9.7.4. Others
9.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
9.9.1. Academic & Research Institutes
9.9.2. Biotechnology companies
9.9.3. Others
9.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
9.11. Drivers and Restraints: Impact Analysis
9.12. Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Cell Type
9.12.3. By Application
9.12.4. By End User
9.13. Key Market Participants – Intensity Mapping
9.14. Drivers and Restraints – Impact Analysis
9.15. Key Mergers & Acquisitions
10. Europe Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
10.3.1. Germany
10.3.2. U.K.
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
10.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
10.5.1. Hepatocytes
10.5.2. Fibroblasts
10.5.3. Keratinocytes
10.5.4. Neurons
10.5.5. Others
10.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
10.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
10.7.1. Drug Development
10.7.2. Toxicity testing
10.7.3. Regenerative Medicine
10.7.4. Others
10.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
10.9.1. Academic & Research Institutes
10.9.2. Biotechnology companies
10.9.3. Others
10.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
10.11. Drivers and Restraints: Impact Analysis
10.12.Market Attractiveness Analysis
10.12.1. By Country
10.12.2. By Cell Type
10.12.3. By Application
10.12.4. By End User
10.13. Key Market Participants – Intensity Mapping
10.14. Drivers and Restraints – Impact Analysis
10.15. Key Mergers & Acquisitions
11. Asia Pacific Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
11.3.1. Japan
11.3.2. India
11.3.3. Australia and New Zealand
11.3.4. Rest of Asia Pacific
11.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
11.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
11.5.1. Hepatocytes
11.5.2. Fibroblasts
11.5.3. Keratinocytes
11.5.4. Neurons
11.5.5. Others
11.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
11.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
11.7.1. Drug Development
11.7.2. Toxicity testing
11.7.3. Regenerative Medicine
11.7.4. Others
11.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
11.9.1. Academic & Research Institutes
11.9.2. Biotechnology companies
11.9.3. Others
11.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
11.11. Drivers and Restraints: Impact Analysis
11.12. Market Attractiveness Analysis
11.12.1. By Country
11.12.2. By Cell Type
11.12.3. By Application
11.12.4. By End User
11.13. Key Market Participants – Intensity Mapping
11.14. Drivers and Restraints – Impact Analysis
11.15. Key Mergers & Acquisitions
12. China Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
12.1. Introduction
12.2. Key Regulations
12.3. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
12.3.1. Hepatocytes
12.3.2. Fibroblasts
12.3.3. Keratinocytes
12.3.4. Neurons
12.3.5. Others
12.4. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
12.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
12.5.1. Drug Development
12.5.2. Toxicity testing
12.5.3. Regenerative Medicine
12.5.4. Others
12.6. Market Size (US$ Mn) Forecast By Application, 2018–2026
12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
12.7.1. Academic & Research Institutes
12.7.2. Biotechnology companies
12.7.3. Others
12.8. Market Size (US$ Mn) Forecast By End User, 2018–2026
12.9. Drivers and Restraints: Impact Analysis
12.10. Market Attractiveness Analysis
12.10.1. By Cell Type
12.10.2. By Application
12.10.3. By End User
12.11. Key Market Participants – Intensity Mapping
12.12. Drivers and Restraints – Impact Analysis
12.13. Key Mergers & Acquisitions
13. Middle East & Africa Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
13.1. Introduction
13.2. Key Regulations
13.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of MEA
13.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
13.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
13.5.1. Hepatocytes
13.5.2. Fibroblasts
13.5.3. Keratinocytes
13.5.4. Neurons
13.5.5. Others
13.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
13.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
13.7.1. Drug Development
13.7.2. Toxicity testing
13.7.3. Regenerative Medicine
13.7.4. Others
13.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
13.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
13.9.1. Academic & Research Institutes
13.9.2. Biotechnology companies
13.9.3. Others
13.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
13.11. Drivers and Restraints: Impact Analysis
13.12. Market Attractiveness Analysis
13.12.1. By Country
13.12.2. By Cell Type
13.12.3. By Application
13.12.4. By End User
13.13. Key Market Participants – Intensity Mapping
13.14. Drivers and Restraints – Impact Analysis
13.15. Key Mergers & Acquisitions
14. Forecast Factors: Relevance and Impact
15. Forecast Assumptions
16. Market Structure Analysis
16.1. Market Structure by Tier of Companies
16.2. Market Share Analysis (2016) for Top Players, By Region
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Company Deep Dive
17.3.1. Thermo Fisher Scientific Inc.
17.3.1.1. Overview
17.3.1.2. Product and Application Portfolio
17.3.1.3. Production Footprint
17.3.1.4. Sales Footprint
17.3.1.5. Channel Footprint
17.3.1.6. Strategy
17.3.1.6.1. Marketing Strategy
17.3.1.6.2. Product Strategy
17.3.1.6.3. Channel Strategy
17.3.2. FUJIFILM Holdings Corporation (Cellular Dynamics)
17.3.2.1. Overview
17.3.2.2. Product and Application Portfolio
17.3.2.3. Production Footprint
17.3.2.4. Sales Footprint
17.3.2.5. Channel Footprint
17.3.2.6. Strategy
17.3.2.6.1. Marketing Strategy
17.3.2.6.2. Product Strategy
17.3.2.6.3. Channel Strategy
17.3.3. Horizon Discovery Group plc.
17.3.3.1. Overview
17.3.3.2. Product and Application Portfolio
17.3.3.3. Production Footprint
17.3.3.4. Sales Footprint
17.3.3.5. Channel Footprint
17.3.3.6. Strategy
17.3.3.6.1. Marketing Strategy
17.3.3.6.2. Product Strategy
17.3.3.6.3. Channel Strategy
17.3.4. Takara Bio Inc.
17.3.4.1. Overview
17.3.4.2. Product and Application Portfolio
17.3.4.3. Production Footprint
17.3.4.4. Sales Footprint
17.3.4.5. Channel Footprint
17.3.4.6. Strategy
17.3.4.6.1. Marketing Strategy
17.3.4.6.2. Product Strategy
17.3.4.6.3. Channel Strategy
17.3.5. Cell Applications, Inc.
17.3.5.1. Overview
17.3.5.2. Product and Application Portfolio
17.3.5.3. Production Footprint
17.3.5.4. Sales Footprint
17.3.5.5. Channel Footprint
17.3.5.6. Strategy
17.3.5.6.1. Marketing Strategy
17.3.5.6.2. Product Strategy
17.3.5.6.3. Channel Strategy
17.3.6. Lonza Group Ltd.
17.3.6.1. Overview
17.3.6.2. Product and Application Portfolio
17.3.6.3. Production Footprint
17.3.6.4. Sales Footprint
17.3.6.5. Channel Footprint
17.3.6.6. Strategy
17.3.6.6.1. Marketing Strategy
17.3.6.6.2. Product Strategy
17.3.6.6.3. Channel Strategy
18. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026, By Region
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
18.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
18.3.1. North America
18.3.2. Latin America
18.3.3. Europe
18.3.4. Asia Pacific
18.3.5. Middle East & Africa
18.3.6. China
18.4. Market Attractiveness Analysis By Region
19. Global Induced Pluripotent Stem Cells Analysis 2013–2017 and Forecast 2018–2026, By Cell Type
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
19.2.1. Hepatocytes
19.2.2. Fibroblasts
19.2.3. Keratinocytes
19.2.4. Neurons
19.2.5. Others
19.3. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
19.4. Market Attractiveness Analysis By Cell Type
20. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026, By Application
20.1. Introduction/Key Findings
20.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
20.2.1. Drug Development
20.2.2. Toxicity testing
20.2.3. Regenerative Medicine
20.2.4. Others
20.3. Market Size (US$ Mn) Forecast By Application, 2018–2026
20.4. Market Attractiveness Analysis By Application
21. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026, By End User
21.1. Introduction/Key Findings
21.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
21.2.1. Academic & Research Institutes
21.2.2. Biotechnology companies
21.2.3. Others
21.3. Market Size (US$ Mn) Forecast By End User, 2018–2026
21.4. Market Attractiveness Analysis By End User
22. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
22.1. Market Value Share Analysis By All Segment
22.2. Y-o-Y Growth Analysis By All Segment
22.3. Absolute $ Opportunity
23. Assumptions and Acronyms
24. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Comparison of Stem Cell Types
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 04: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 05: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 06: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 07: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 08: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 09: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 10: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 11: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 12: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 13: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 14: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 15: North America Induced Pluripotent Stem Cell Market Company Intensity Map
Table 16: Economic support and stem cell research for the major countries in Latin America, (2013)
Table 17: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 18: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 19: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 20: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 21: Latin America Induced Pluripotent Stem Cell Market Company Intensity Map
Table 22: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 23: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 24: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 25: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 26: Europe Induced Pluripotent Stem Cell Market Company Intensity Map
Table 27: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 28: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 29: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 30: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 31: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Company Intensity Map
Table 32: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 33: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 34: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 35: China Induced Pluripotent Stem Cell Market Company Intensity Map
Table 36: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 37: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 38: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 39: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 40: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Company Intensity Map
Table 41: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
Table 42: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 43: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 44: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: All R&D expenditure, by Source of Fund, 2011
Figure 02: R&D expenditure in Life Science, by R&D Field, 2011
Figure 03: Leading cause of Death, 2014
Figure 04: Global Stem Cell Market Overview (2016E)
Figure 05: Main Obstacles in Stem Cell Research
Figure 06: Number of Companies (estimated) Offering iPSC Research products, by Year
Figure 07: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 08: The Number of Estimated Active Researchers in Stem Cell Research Worldwide
Figure 09: North America Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 10: North America Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 11: iPSC Specific U.S. Patents, by patent type, 2015
Figure 12: National contribution to iPSC invention, by country, 2014
Figure 13: Total number of patents for iPSC technologies (Est.)
Figure 14: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 15: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 16: North America Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 17: U.S. Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 18: U.S. Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 19: Canada Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 20: Canada Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 21: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 22: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 23: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 24: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 25: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 26: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 27: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 28: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 29: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 30: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 31: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
Figure 32: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 33: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 34: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 35: Latin America Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 36: Latin America Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 37: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 38: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 39: Latin America Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 40: Brazil Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 41: Brazil Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 42: Mexico Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 43: Mexico Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 44: Argentina Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 45: Argentina Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 46: Rest of Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 47: Rest of Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 48: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 49: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 50: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 51: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 52: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 53: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 54: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 55: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 56: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 57: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 58: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
Figure 59: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 60: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 61: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 62: Europe Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 63: Europe Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 64: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 65: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 66: Europe Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 67: Germany Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 68: Germany Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 69: U.K. Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 70: U.K. Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 71: France Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 72: France Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 73: Italy Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 74: Italy Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 75: Spain Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 76: Spain Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 77: Russia Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 78: Russia Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 79: Rest of Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 80: Rest of Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 81: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 82: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 83: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 84: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 85: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 86: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 87: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 88: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 89: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 90: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 91: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
Figure 92: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 93: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 94: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 95: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 96: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 97: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 98: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 99: APEC Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 100: Japan Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 101: Japan Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 102: India Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 103: India Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 104: Australia and New Zealand Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 105: Australia and New Zealand Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 106: Rest of APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 107: Rest of APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 108: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 109: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 110: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 111: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 112: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 113: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 114: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 115: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 116: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 117: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 118: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
Figure 119: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 120: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 121: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 123: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 124: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 125: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 126: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 127: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 128: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 129: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 130: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 131: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 132: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 133: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 134: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 135: China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
Figure 136: China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 137: China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 138: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 139: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 140: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 141: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 142: MEA Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 143: GCC Countries Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 144: GCC Countries Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 145: South Africa Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 146: South Africa Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 147: Rest of MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 148: Rest of MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 149: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 150: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 151: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 152: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 153: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 154: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 155: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 156: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 157: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 158: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 159: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
Figure 160: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 161: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 162: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 163: Revenue Contribution by Tier Type (2016)
Figure 164: Global Induced Pluripotent Stem Cell Market Share (%) Analysis
Figure 165: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Region
Figure 166: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
Figure 167: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 168: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 169: Global Induced Pluripotent Stem Cell Market Size and Y-o-Y, 2013 - 2017
Figure 170: Global Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 171: Global Induced Pluripotent Stem Cell Market Absolute $ Opportunity, 2017–2026
